Butanol fraction containing berberine or related compound from nexrutine inhibits NFkappaB signaling and induces apoptosis in prostate cancer cells
about
New Potential Pharmacological Functions of Chinese Herbal Medicines via Regulation of AutophagyTransportation of berberine into HepG2, HeLa and SY5Y cells: a correlation to its anti-cancer effectPalmatine inhibits growth and invasion in prostate cancer cell: Potential role for rpS6/NFκB/FLIP.Inhibition of PI3K/AKT/mTOR axis disrupts oxidative stress-mediated survival of melanoma cells.Tolerance of Phellodendron amurense bark extract (Nexrutine®) in patients with human prostate cancerExtracting the Benefit of Nexrutine® for Cancer Prevention.Berberine protects rat heart from ischemia/reperfusion injury via activating JAK2/STAT3 signaling and attenuating endoplasmic reticulum stress.Screening the active compounds of Phellodendri Amurensis cortex for treating prostate cancer by high-throughput chinmedomics.Downregulation of STAT3/NF-κB potentiates gemcitabine activity in pancreatic cancer cells.Cytotoxic Effect of Coscinium fenestratum on Human Head and Neck Cancer Cell Line (HN31).Nexrutine inhibits survival and induces G1 cell cycle arrest, which is associated with apoptosis or autophagy depending on the breast cancer cell line.Dietary administration of Nexrutine inhibits rat liver tumorigenesis and induces apoptotic cell death in human hepatocellular carcinoma cells.Topical application of Nexrutine inhibits ultraviolet B-induced cutaneous inflammatory responses in SKH-1 hairless mouse.Palmatine suppresses glutamine-mediated interaction between pancreatic cancer and stellate cells through simultaneous inhibition of survivin and COL1A1.Dietary administration of berberine or Phellodendron amurense extract inhibits cell cycle progression and lung tumorigenesis.
P2860
Q26753053-BE5E08A6-70C2-40F3-A4A1-E534450E7333Q28544999-7A4AA391-686F-421E-9981-274E8E33A874Q34429968-E2F6F7C7-66AD-4FA6-B463-626CDEE39E2EQ34466148-8E4BF598-EBF7-4B21-A528-0396CD774FE6Q35865808-3D6762C3-F436-4AC0-A8E0-95BE6761F2B1Q36236997-E85538B6-58AB-45BB-91AD-4E7F7766D9B1Q36644283-D5F82A7E-B591-4054-94B8-5BAC642B7CADQ37739702-67D534BB-25C1-4FBC-AC16-2F42CA68C041Q38769440-81BBD6F7-5553-42BB-8015-5E5062305753Q38864064-DD4243D0-4F5E-4760-9C14-FF47E503EFD7Q39065633-40B86CEB-DE82-43EB-9490-2BCB3A131614Q41680876-3A3A9168-1920-4F27-A6FD-462D6BBF875EQ47878573-80785256-98CF-40B0-84FD-F0958F9EB67DQ50135698-2B30A74D-0803-4F05-931A-D9FF965086D4Q54634175-620377A7-75F0-4174-BDB8-B1C0C78AC976
P2860
Butanol fraction containing berberine or related compound from nexrutine inhibits NFkappaB signaling and induces apoptosis in prostate cancer cells
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Butanol fraction containing be ...... tosis in prostate cancer cells
@ast
Butanol fraction containing be ...... tosis in prostate cancer cells
@en
Butanol fraction containing be ...... tosis in prostate cancer cells
@nl
type
label
Butanol fraction containing be ...... tosis in prostate cancer cells
@ast
Butanol fraction containing be ...... tosis in prostate cancer cells
@en
Butanol fraction containing be ...... tosis in prostate cancer cells
@nl
prefLabel
Butanol fraction containing be ...... tosis in prostate cancer cells
@ast
Butanol fraction containing be ...... tosis in prostate cancer cells
@en
Butanol fraction containing be ...... tosis in prostate cancer cells
@nl
P2093
P2860
P356
P1433
P1476
Butanol fraction containing be ...... tosis in prostate cancer cells
@en
P2093
A B Kunnumakkara
Addanki P Kumar
Bharat B Aggarwal
Bhaskaran Shylesh
Ghosh Rita
Kaustubh H Kulkarni
Sri Balasubashini Muralimanoharan
P2860
P304
P356
10.1002/PROS.20899
P407
P577
2009-04-01T00:00:00Z